CONTINUE TO SITE
OR WAIT null SECS
Advertisement
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
How a Lack of Critical Thinking is Hindering Regulatory Compliance
Published on:
Calvin Kim
Pharmaceutical Technology, Pharmaceutical Technology, Regulatory Sourcebook, March 2022, Volume 2022 eBook, Issue 1
Pages: 34–39
Why critical thinking must be applied before technology to ensure regulatory compliance.
Throughout a single project, contract development and manufacturing organizations (CDMOs) generate an abundance of essential data that require an array of computerized systems to manage. These systems provide many benefits, including reducing human error, making processes more efficient, and enhancing security. More importantly, these systems can be used to help implement technical controls for data integrity (DI).
The importance of ensuring DI, particularly when data are used in decision-making for the regulated good practice (GxP) processes, is highlighted by the consistent updating of regulations first mandated by FDA in the early 1960s. Since that time, FDA and other regulatory agencies have continued to publish guidance emphasizing the need to maintain DI controls.
Before any new technology implementation, CDMOs need to fully understand the system as well as establish its intended use and perform risk mitigation to ensure robust DI controls. However, understanding and implementing the requirements of regulations surrounding computerized systems continues to be a challenge to many CDMOs today. Technology is not the predominant challenge to achieving regulatory compliance, but the lack of critical thinking skills when designing a quality system.
Read this article in Pharmaceutical Technology's March 2022 Quality and Regulatory Sourcebook eBook.
Advertisement
About the author
Calvin Kim is the senior director, head of IT quality systems and validation, for Samsung Biologics.
Article details
Pharmaceutical Technology
eBook: Quality and Regulatory Sourcebook
March 2022
Pages: 34–39
Citation
When referring to this article, please cite it as C. Kim, "How a Lack of Critical Thinking is Hindering Regulatory Compliance," Pharmaceutical Technology's Quality and Regulatory Sourcebook eBook (March 2022).
